Alkeon Capital Management’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-1,547,875
| Closed | -$38.4M | – | 102 |
|
|
2023
Q2 | $38.4M | Sell |
1,547,875
-1,142,048
| -42% | -$28.4M | 0.07% | 62 |
|
|
2023
Q1 | $40.5M | Sell |
2,689,923
-354,494
| -12% | -$5.33M | 0.09% | 60 |
|
|
2022
Q4 | $36M | Buy |
3,044,417
+1,401,742
| +85% | +$16.6M | 0.14% | 66 |
|
|
2022
Q3 | $9.73M | Sell |
1,642,675
-124,455
| -7% | -$737K | 0.03% | 94 |
|
|
2022
Q2 | $7.51M | Sell |
1,767,130
-30,880
| -2% | -$131K | 0.02% | 99 |
|
|
2022
Q1 | $17.1M | Sell |
1,798,010
-70,291
| -4% | -$668K | 0.03% | 96 |
|
|
2021
Q4 | $35.5M | Sell |
1,868,301
-2,200,000
| -54% | -$41.8M | 0.07% | 97 |
|
|
2021
Q3 | $135M | Sell |
4,068,301
-14,194
| -0.3% | -$472K | 0.23% | 72 |
|
|
2021
Q2 | $158M | Sell |
4,082,495
-8,196
| -0.2% | -$318K | 0.23% | 63 |
|
|
2021
Q1 | $197M | Buy |
4,090,691
+12,533
| +0.3% | +$604K | 0.29% | 51 |
|
|
2020
Q4 | $212M | Buy |
4,078,158
+1,303,158
| +47% | +$67.8M | 0.35% | 43 |
|
|
2020
Q3 | $74.3M | Buy |
2,775,000
+510,000
| +23% | +$13.6M | 0.14% | 75 |
|
|
2020
Q2 | $44.1M | Buy |
2,265,000
+700,000
| +45% | +$13.6M | 0.11% | 83 |
|
|
2020
Q1 | $15.4M | Buy |
1,565,000
+565,000
| +57% | +$5.56M | 0.07% | 91 |
|
|
2019
Q4 | $11.1M | Buy |
+1,000,000
| New | +$11.1M | 0.04% | 79 |
|